1-4 of 4
Kathryn W. Woodburn
Close
Sort by
Journal Articles

Erythropoiesis Equivalence, Pharmacokinetics and Antibody Analysis Following Subcutaneous and Intravenous Hematide™ Administration in Cynomolgus Monkeys.

Kathryn W. Woodburn, PhD, Peter J. Schatz, PhD, Kei-lai Fong, PhD, Paul L. Beaumier, PhD
Journal: Blood
Blood (2006) 108 (11): 1143.
https://doi.org/10.1182/blood.V108.11.1143.1143
Published: 2006
Journal Articles

Chronic Preclinical Safety Evaluation of Hematide ™ , a PEGylated Peptidic Erythropoiesis Stimulating Agent, in Monkeys.

Kathryn W. Woodburn, PhD, Peter J. Schatz, PhD, Kei-lai Fong, PhD, Thomas Ferrell, Charles B. Spainhour, VMD, PhD, DABT, Daniel Norton, PhD
Journal: Blood
Blood (2006) 108 (11): 1155.
https://doi.org/10.1182/blood.V108.11.1155.1155
Published: 2006
Journal Articles

Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers

Clinical Trials & Observations
Richard B. Stead, John Lambert, Dawie Wessels, Julie S. Iwashita, Kerstin K. Leuther, Kathryn W. Woodburn, Peter J. Schatz, Douglas M. Okamoto, Robert Naso, Anne-Marie Duliege
Journal: Blood
Blood (2006) 108 (6): 1830–1834.
https://doi.org/10.1182/blood-2006-04-015818
Published: 2006
Journal Articles

Preclinical Evaluation of Hematide™, a Novel Erythropoietic Receptor Agonist for the Treatment of Anemia Caused by Kidney Disease.

Kathryn W. Woodburn, PhD, Qing Fan, MD, Kerstin K. Leuther, PhD, Christopher P. Holmes, PhD, Jim J. Zhang, PhD, Svetlana Velkovska, MS, Min-jia Chen, MD, MS, Peter J. Schatz, PhD
Journal: Blood
Blood (2004) 104 (11): 2904.
https://doi.org/10.1182/blood.V104.11.2904.2904
Published: 2004